This inventor holds 1 USPTO granted patent. Top assignee: King Saud University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Eman Ahmed Ibrahim Mazyed: Innovator in Nanoformulation for Cancer Treatment
Introduction
Eman Ahmed Ibrahim Mazyed is a notable inventor based in Riyadh, Saudi Arabia. She has made significant contributions to the field of medical science, particularly in the area of cancer treatment. Her innovative work focuses on the development of nanoformulations that can enhance therapeutic efficacy.
Latest Patents
Eman holds a patent titled "Nanoformulation of spirooxindole and methods for treating hepatocellular carcinoma." This patent describes a spirooxindole nanoformulation that includes a proniosome loaded with a spirooxindole derivative. The specific compound involved in this formulation is identified as Compound 4d. This advancement has the potential to improve treatment options for patients suffering from liver cancer.
Career Highlights
Eman is affiliated with King Saud University, where she engages in research and development activities. Her work at the university allows her to collaborate with other experts in the field and contribute to groundbreaking research initiatives.
Collaborations
Eman has worked alongside esteemed colleagues such as Assem Barakat and Fardous F El-Senduny. These collaborations have enriched her research and expanded the impact of her innovations.
Conclusion
Eman Ahmed Ibrahim Mazyed is a pioneering inventor whose work in nanoformulation represents a significant advancement in cancer treatment. Her contributions are poised to make a lasting impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile